These results indicate that a PRS could be informative in predicting individualised cancer risk for BRCA1/2 variant carriers, a small but important group of men due to their high-risk status and could form the basis of an enhanced screening strategy for BRCA1/2 variant carriers (Fig. 5). The gene discussed is BRCA1; the disease is cancer.